Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls.

Glisic S, Ehlenbach S, Jailwala P, Waukau J, Jana S, Ghosh S.

Cell Tissue Res. 2010 Mar;339(3):585-95. doi: 10.1007/s00441-009-0900-0. Epub 2010 Feb 9.

PMID:
20143240
2.

Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.

Du W, Shen YW, Lee WH, Wang D, Paz S, Kandeel F, Liu CP.

PLoS One. 2013;8(2):e56209. doi: 10.1371/journal.pone.0056209. Epub 2013 Feb 11.

3.

Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.

Aghili B, Amirzargar AA, Rajab A, Rabbani A, Sotoudeh A, Assadiasl S, Larijani B, Massoud A.

Iran J Immunol. 2015 Dec;12(4):240-51. doi: IJIv12i4A2.

4.

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.

Schmidt A, Éliás S, Joshi RN, Tegnér J.

J Vis Exp. 2016 Dec 30;(118). doi: 10.3791/55015.

PMID:
28060341
5.

Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.

Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.

Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x. Epub 2008 Apr 10.

PMID:
18410422
6.

Natural and inducible Tregs in swine: Helios expression and functional properties.

Käser T, Mair KH, Hammer SE, Gerner W, Saalmüller A.

Dev Comp Immunol. 2015 Apr;49(2):323-31. doi: 10.1016/j.dci.2014.12.005. Epub 2014 Dec 12.

PMID:
25511662
7.

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x. Epub 2009 Jan 24.

8.

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.

Glisic-Milosavljevic S, Waukau J, Jailwala P, Jana S, Khoo HJ, Albertz H, Woodliff J, Koppen M, Alemzadeh R, Hagopian W, Ghosh S.

PLoS One. 2007 Jan 3;2(1):e146.

9.

Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.

McGee HS, Agrawal DK.

Am J Respir Crit Care Med. 2009 Aug 1;180(3):211-25. doi: 10.1164/rccm.200809-1505OC. Epub 2009 May 15.

10.

Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.

Hamari S, Kirveskoski T, Glumoff V, Kulmala P, Simell O, Knip M, Veijola R.

Scand J Immunol. 2016 Apr;83(4):279-87. doi: 10.1111/sji.12418.

11.

Expansion of human regulatory T-cells from patients with type 1 diabetes.

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA.

Diabetes. 2009 Mar;58(3):652-62. doi: 10.2337/db08-1168. Epub 2008 Dec 15.

12.

Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.

Jaberi-Douraki M, Pietropaolo M, Khadra A.

J Theor Biol. 2015 Oct 21;383:93-105. doi: 10.1016/j.jtbi.2015.07.032. Epub 2015 Aug 10.

13.

Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five.

Szypowska A, Stelmaszczyk-Emmel A, Demkow U, Luczyński W.

Arch Immunol Ther Exp (Warsz). 2012 Aug;60(4):307-13. doi: 10.1007/s00005-012-0177-y. Epub 2012 Jun 9.

PMID:
22684085
14.

T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.

Parackova Z, Kayserova J, Danova K, Sismova K, Dudkova E, Sumnik Z, Kolouskova S, Lebl J, Stechova K, Sediva A.

Autoimmunity. 2016 Dec;49(8):523-531. Epub 2016 Aug 25.

PMID:
27560779
15.

Role of regulatory T cells for the treatment of type 1 diabetes mellitus.

Jaeckel E, Mpofu N, Saal N, Manns MP.

Horm Metab Res. 2008 Feb;40(2):126-36. doi: 10.1055/s-2008-1042427. Review.

PMID:
18283631
16.
17.

Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.

Zhen Y, Sun L, Liu H, Duan K, Zeng C, Zhang L, Jin D, Peng J, Ding W, Zhao Y.

Cell Mol Immunol. 2012 Jan;9(1):75-85. doi: 10.1038/cmi.2011.37. Epub 2011 Oct 10.

18.

Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes.

Hughson A, Bromberg I, Johnson B, Quataert S, Jospe N, Fowell DJ.

Diabetes. 2011 Aug;60(8):2125-33. doi: 10.2337/db10-1661. Epub 2011 Jun 29.

19.

Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.

Zhang P, Tey SK, Koyama M, Kuns RD, Olver SD, Lineburg KE, Lor M, Teal BE, Raffelt NC, Raju J, Leveque L, Markey KA, Varelias A, Clouston AD, Lane SW, MacDonald KP, Hill GR.

J Immunol. 2013 Nov 15;191(10):5291-303. doi: 10.4049/jimmunol.1301181. Epub 2013 Oct 11.

20.

Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.

Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, Degutes M, Miller SD, Luo X.

Am J Transplant. 2010 Aug;10(8):1774-84. doi: 10.1111/j.1600-6143.2010.03199.x. Epub 2010 Jul 12.

Supplemental Content

Support Center